Literature DB >> 24941377

NK cells and virus-related cancers.

Rabinarayan Mishra1, Raymond Welsh1, Eva Szomolanyi-Tsuda1.   

Abstract

Natural killer (NK) cells become activated during viral infections and can play roles in such infections by attacking virus-infected cells or by regulating adaptive immune responses. Experimental models suggest that NK cells may also have the capacity to restrain virus-induced cancers. Here, we discuss the seven viruses linked to human cancers and the evidence of NK cell involvement in these systems.

Entities:  

Mesh：

Year:  2014        PMID： 24941377      PMCID： PMC4196716          DOI： 10.1615/critrevoncog.2014010866

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN： 0893-9675


  93 in total

1.  Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity.

Authors:  Philipp A Lang; Karl S Lang; Haifeng C Xu; Melanie Grusdat; Ian A Parish; Mike Recher; Alisha R Elford; Salim Dhanji; Namir Shaabani; Charles W Tran; Dilan Dissanayake; Ramtin Rahbar; Magar Ghazarian; Anne Brüstle; Jason Fine; Peter Chen; Casey T Weaver; Christoph Klose; Andreas Diefenbach; Dieter Häussinger; James R Carlyle; Susan M Kaech; Tak W Mak; Pamela S Ohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-13       Impact factor: 11.205

2.  The immune response to primary EBV infection: a role for natural killer cells.

Authors:  Hilary Williams; Karen McAulay; Karen F Macsween; Neil J Gallacher; Craig D Higgins; Nadine Harrison; Anthony J Swerdlow; Dorothy H Crawford
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

3.  Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD.

Authors:  Silke Wiesmayr; Steven A Webber; Camila Macedo; Iulia Popescu; Louise Smith; Jane Luce; Diana Metes
Journal:  Eur J Immunol       Date:  2011-12-16       Impact factor: 5.532

4.  NK cell functions restrain T cell responses during viral infections.

Authors:  H C Su; K B Nguyen; T P Salazar-Mather; M C Ruzek; M Y Dalod; C A Biron
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

5.  The NK cell response to mouse cytomegalovirus infection affects the level and kinetics of the early CD8(+) T-cell response.

Authors:  Maja Mitrović; Jurica Arapović; Stefan Jordan; Nassima Fodil-Cornu; Stefan Ebert; Silvia M Vidal; Astrid Krmpotić; Matthias J Reddehase; Stipan Jonjić
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

6.  Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.

Authors:  Kelly G Paulson; Jayasri G Iyer; Andrew R Tegeder; Renee Thibodeau; Janell Schelter; Shinichi Koba; David Schrama; William T Simonson; Bianca D Lemos; David R Byrd; David M Koelle; Denise A Galloway; J Helen Leonard; Margaret M Madeleine; Zsolt B Argenyi; Mary L Disis; Juergen C Becker; Michele A Cleary; Paul Nghiem
Journal:  J Clin Oncol       Date:  2011-03-21       Impact factor: 44.544

Review 7.  Natural killer T cells and X-linked lymphoproliferative syndrome.

Authors:  Sylvain Latour
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-12

8.  Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo.

Authors:  Marina Babić; Michal Pyzik; Biljana Zafirova; Maja Mitrović; Višnja Butorac; Lewis L Lanier; Astrid Krmpotić; Silvia M Vidal; Stipan Jonjić
Journal:  J Exp Med       Date:  2010-11-15       Impact factor: 14.307

9.  Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.

Authors:  Emily M Mace; Amy P Hsu; Linda Monaco-Shawver; George Makedonas; Joshua B Rosen; Lesia Dropulic; Jeffrey I Cohen; Eugene P Frenkel; John C Bagwell; John L Sullivan; Christine A Biron; Christine Spalding; Christa S Zerbe; Gulbu Uzel; Steven M Holland; Jordan S Orange
Journal:  Blood       Date:  2013-01-30       Impact factor: 22.113

10.  Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.

Authors:  Prabal Banerjee; Gerold Feuer; Edward Barker
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103
View more
  6 in total

1.  A regulatory mutant on TRIM26 conferring the risk of nasopharyngeal carcinoma by inducing low immune response.

Authors:  Xiao-Ming Lyu; Xiao-Wei Zhu; Manli Zhao; Xian-Bo Zuo; Zhong-Xi Huang; Xiao Liu; Tao Jiang; Xue-Xi Yang; Xin Li; Xiao-Bing Long; Jian-Guo Wang; Jin-Bang Li; Ming-Yu Han; Shuang Wang; Teng-Fei Liu; Bo Zhang; Tao Sun; Zhi Cheng; Mo-Chang Qiu; Lei Dong; Lu Zheng; Long-Cheng Zhang; Jia-Hong Wang; Gan-Guan Wei; Kaitai Yao; Qian Wang; Hou-Feng Zheng; Xin Li
Journal:  Cancer Med       Date:  2018-06-28       Impact factor: 4.452

2.  Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia.

Authors:  Austin B Henslee; Timothy A Steele
Journal:  Biomark Res       Date:  2018-08-09

Review 3.  The Role of NK Cells in EBV Infection and EBV-Associated NPC.

Authors:  Yi Tian Png; Audrey Zhi Yi Yang; Mei Ying Lee; Magdalene Jahn May Chua; Chwee Ming Lim
Journal:  Viruses       Date:  2021-02-15       Impact factor: 5.048

4.  Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.

Authors:  Shoeib Moradi; Sanda Stankovic; Geraldine M O'Connor; Phillip Pymm; Bruce J MacLachlan; Camilla Faoro; Christelle Retière; Lucy C Sullivan; Philippa M Saunders; Jacqueline Widjaja; Shea Cox-Livingstone; Jamie Rossjohn; Andrew G Brooks; Julian P Vivian
Journal:  Nat Commun       Date:  2021-04-12       Impact factor: 14.919

Review 5.  Does Natural Killer Cell Deficiency (NKD) Increase the Risk of Cancer? NKD May Increase the Risk of Some Virus Induced Cancer.

Authors:  Won Young Moon; Simon J Powis
Journal:  Front Immunol       Date:  2019-07-19       Impact factor: 7.561

6.  The Toll-Like Receptor 3 Agonist Polyriboinosinic Polyribocytidylic Acid Increases the Numbers of NK Cells with Distinct Phenotype in the Liver of B6 Mice.

Authors:  Mohamed L Salem; Sabry A El-Naggar; Maysa A Mobasher; Rehab M Elgharabawy
Journal:  J Immunol Res       Date:  2020-03-05       Impact factor: 4.818
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.